Browse diseases

…, monitoring, and treatment needs to be established. Given that MASLD is a multisystem disease, assessing cost effectiveness should c…

…with higher MASLD risk than discordantly high LDL-C, even among T2DM patients with optimal LDL-C and TG levels. Moreover, RC is asso…

…kin-6; LN, laminin; LDL-C, low-density lipoprotein cholesterol; MASLD, metabolic dysfunction-associated steatotic liver disease; PC I…

…n (IQR) of 12.5 (11.8–13.2) years, 423 (3.2%) participants with type 2 diabetes and 2758 (0.9%) participants without diabetes developed MALO. P…

…atohepatitisAlteration of demographic & metabolic parameters in steatohepatitis subjects with or without T2DParameters (normal value)T2D (N=40)…

… and nurse respondentsNAFLD: non-alcoholic fatty liver disease, MASLD: metabolic dysfunction-associated steatotic liver disease, MetA…

… in SAFE score corresponded to a 0.05-point increase in 10-year ASCVD risk, B=0.05, SE=0.005, p<0.001 (figure 1D). The findings sugge…

…Background Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide.…

…ned with AST and ALT.Conclusions In this group of patients with MASLD, sASGR1 levels are higher and are associated with the occurrenc…

…CKD ( table 1).Table 1Baseline characteristics of patients with T2DM and hypertension stratified by FIB-4 indexTotal (n=1208)FIB-4 ≤…

…incidence rates of hypertension and CVE were similar. New-onset diabetes occurred in 15% of HIV and 25% of non-HIV recipients (p=0.052) …

…bule. It showed that inflammation burden was higher in AIH than MASLD/MASH, despite equivalent portal grades, providing objective sup…